News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Deals
Genentech, Inc. (JOBS) CEO Sells 90,000 Shares Prior to Roche (JOBS) Bid
July 23, 2008
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
NEW YORK (Reuters) - If there was any doubt that Genentech Inc was caught by surprise by Roche's move to acquire the remaining stake in the biotechnology giant it doesn't already own, one need only look at recent executive stock transactions.
Twitter
LinkedIn
Facebook
Email
Print
Mergers & acquisitions
Genentech, Inc.
Roche
MORE ON THIS TOPIC
Cancer
Pfizer Searches for Novel Tumor-Selective Antigens With $865M+ Cartography Pact
January 7, 2026
·
2 min read
·
Tristan Manalac
Mergers & acquisitions
Amgen Makes up to $840M Cancer Play With Dark Blue Takeover
January 7, 2026
·
1 min read
·
Tristan Manalac
Podcast
Novo Launches Oral Obesity Pill, Lilly Targets Lofty Revenue, FDA and M&A in Focus
January 7, 2026
·
2 min read
·
Heather McKenzie
Insights
Biotech Investors Bet on a 2026 Rebound as Deal Activity Accelerates
January 7, 2026
·
3 min read
·
Jennifer Smith-Parker